Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
A minute's silence will be observed at 11am on Thursday in remembrance of those who lost their lives in the Manchester Arena attack.
New research has found those who consumed two cups had a 35% reduced risk, and for those who drank five cups, the risk halved.
New research has found #Brexit was the most commonly occurring hashtag for abusive tweets.